首页> 外文期刊>Molecular Cancer >The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression
【24h】

The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression

机译:HPV-16 E7癌蛋白通过放松Polo样激酶4表达来诱导中心粒增殖

获取原文
获取外文期刊封面目录资料

摘要

Background Infection with high-risk human papillomaviruses (HPVs) such as HPV-16 is intimately associated with squamous cell carcinomas (SCCs) of the anogenital tract and a subset of oropharyngeal carcinomas. Such lesions, including pre-invasive precursors, frequently show multipolar mitoses and aneuploidy. The high-risk HPV-16-encoded E7 oncoprotein has been shown to rapidly induce centrosome abnormalities thereby causing the formation of supernumerary mitotic spindle poles and increasing the risk for chromosome missegregation. HPV-16 E7 has been found to rapidly induce centriole overduplication, in part, through the simultaneous formation of more than one daughter centriole at single maternal centrioles (centriole multiplication). The precise molecular mechanism that underlies HPV-16 E7-induced centriole multiplication, however, remains poorly understood. Findings Here, we show that human keratinocytes engineered to stably express the HPV-16 E7 oncoprotein exhibit aberrant Polo -like kinase 4 (PLK4) protein expression at maternal centrioles. Real-time quantitative reverse transcriptase (qRT-PCR) analysis of these cells revealed an increase of PLK4 mRNA levels compared to control cells. Importantly, the ability of the HPV-16 E7 oncoprotein to induce centriole multiplication was found to correlate with its ability to activate the PLK4 promoter and to up-regulate PLK4 mRNA . Conclusions These results highlight the critical role of PLK4 transcriptional deregulation in centriole multiplication in HPV-16 E7-expressing cells. Our findings encourage further experiments to test transcriptional inhibitors or small molecules targeting PLK4 to prevent centriole abnormalities, mitotic infidelity and malignant progression in HPV-associated neoplasms and other tumors in which PLK4 regulation is disrupted.
机译:背景技术感染高危型人乳头瘤病毒(HPVs),例如HPV-16,与生殖道鳞状细胞癌(SCC)和部分口咽癌密切相关。包括侵入前体在内的此类病变经常表现出多极有丝分裂和非整倍性。高风险的HPV-16编码的E7癌蛋白已显示可快速诱导中心体异常,从而导致形成多余的有丝分裂纺锤体极并增加染色体错聚的风险。已发现,HPV-16 E7可以部分地通过在单个母体中心同时形成多个子中心(中心体增殖)而迅速诱导中心体过度复制。然而,对于HPV-16 E7诱导的中心粒增殖的精确分子机制仍然知之甚少。在这里的发现,我们表明,工程改造为稳定表达HPV-16 E7癌蛋白的人角质形成细胞在母体中心细胞上表现出异常的Polo样激酶4(PLK4)蛋白表达。这些细胞的实时定量逆转录酶(qRT-PCR)分析显示,与对照细胞相比,PLK4 mRNA水平增加。重要的是,发现HPV-16 E7癌蛋白诱导中心体增殖的能力与其激活PLK4启动子和上调PLK4 mRNA的能力有关。结论这些结果突显了PLK4转录失调在表达HPV-16 E7的细胞的中心粒增殖中的关键作用。我们的发现鼓励进一步的实验来测试针对PLK4的转录抑制剂或小分子,以预防HPV相关肿瘤和其他PLK4调节被破坏的肿瘤的中心异常,有丝分裂不忠和恶性进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号